Effects of maternal preeclampsia | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fully adjusteda) | Final analysisb) | |||||||||||
n | Mild/moderate preeclampsia | Severe preeclampsia | Likelihood-ratio- | n | Mild/moderate preeclampsia | Severe preeclampsia | Likelihood-ratio | |||||
Outcome variable | OR | 95% CI | OR | 95% CI | p | OR | 95% CI | OR | 95% CI | p | ||
FU1 variables | ||||||||||||
Allergic rhinoconjunctivitis | 514 | 1.21 | (0.70, 2.07) | 2.10 | (0.86, 5.11) | 0.268 | 586 | 1.25 | (0.79, 1.97) | 2.23 | (1.20, 4.17) | 0.046 |
Atopic dermatitis | 513 | 0.90 | (0.54, 1.50) | 0.97 | (0.39, 2.39) | 0.914 | ____ | |||||
Asthma | 506 | 0.87 | (0.38, 1.97) | 0.72 | (0.19, 2.77) | 0.878 | ____ | |||||
FU2 variables | ||||||||||||
Allergic sensitization | 329 | 1.49 | (0.84, 2.63) | 2.44 | (0.93, 6.42) | 0.138 | ____ | |||||
High level allergic sensitizationc) | 329 | 1.64 | (0.87, 3.11) | 4.42 | (1.58, 12.3) | 0.015 | 347 | 1.60 | (0.88, 2.91) | 4.05 | (1.62, 10.1) | 0.010d) |
Current asthma | 388 | 1.11 | (0.45, 2.73) | 0.69 | (0.15, 3.18) | 0.802 | ____ |